Skip to main content
Division of Cancer Prevention
Division of Cancer Prevention

Search form

Making cancer prevention possible

Main menu

  • Home
  • Major Programs
    • Cancer Prevention Fellowship Program (CPFP)
    • Early Detection Research Network (EDRN)
    • NCI Community Oncology Research Program (NCORP)
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
    • Cancer Screening Research Network (CSRN)
    • Cancer Treatment Tolerability Consortium
    • Consortium for Imaging and Biomarkers (CIB)
    • HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
    • Liquid Biopsy Consortium
    • Lung Cancer Screening Image Library
    • Multi-Cancer Detection (MCD) Research
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational and Basic Science Research in Early Lesions (TBEL) Program
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
  • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials Search
    • Landmark Trials
    • Clinical Trials Management
    • Why I Joined a Clinical Trial
  • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
  • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System
  • News & Events
    • News
      • CP-CTNet Newsletter - September 2022
    • Blog
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • Scientific Scope
    • Commemoration of the 50th Anniversary of the National Cancer Act
    • Director
    • DCP Leadership
    • History and Timeline
    • Historical Resources
    • Staff Directory

You are here

  1. Home
  2.   »  Research Groups
  3.   »  Breast and Gynecologic Cancer
  4.   »  Breast and Gynecologic Cancer Staff
  • Biometry
  • Breast and Gynecologic Cancer
    • About the Breast and Gynecologic Cancer Research Group
    • Active Grants
    • Clinical Trials
    • Funding Opportunities
    • How Patients and Their Doctors Determine Cancer Risk—and What Happens Next
    • Making Informed Choices on Incorporating Chemoprevention Into Breast Care: Q & A with Dr. Katherine Crew on the MiCHOICE Trial
    • Publications
    • Staff
  • Cancer Biomarkers
  • Chemopreventive Agent Development
  • Community Oncology and Prevention Trials
  • Early Detection
  • Gastrointestinal and Other Cancers
  • Lung and Upper Aerodigestive Cancer
  • Nutritional Science
  • Prostate and Urologic Cancer

Contact the Breast and Gynecologic Cancer Research Group

Phone: 240-276-7051
Fax: 240-276-7828

For Regular Mail

Breast and Gynecologic Cancer Research Group, DCP, NCI
9609 Medical Center Drive
MSC 9783
Bethesda, MD 20892-9783

For Courier Packages

Breast and Gynecologic Cancer Research Group, DCP, NCI
9609 Medical Center Drive
Rockville, MD 20850

Breast and Gynecologic Cancer Staff

Mela Asefa
240-276-6422
asefamk@mail.nih.gov
Mela Asefa
Emma Brofsky, M.S.P.H.
240-276-7532
brofskyej@mail.nih.gov
Portrait of Emma Brofsky, M.S.P.H.
Eileen Dimond, R.N., M.S.
240-276-7086
dimonde@mail.nih.gov
Portrait of Eileen Dimond, R.N., M.S.
Silvina Frech, Ph.D., M.S.
frechms@mail.nih.gov
Brandy Heckman-Stoddard, Ph.D., M.P.H.
240-276-7048
heckmanbm@mail.nih.gov
Portrait of Brandy Heckman-Stoddard, Ph.D., M.P.H.
Marjorie Perloff, M.D.
240-276-7097
perloffm@mail.nih.gov
Marjorie Perloff, M.D.
Esmeralda Ramirez-Peña, Ph.D., M.P.H.
240-276-7006
ramirezpenaeq@mail.nih.gov
Portrait of Esmeralda Ramirez-Peña
Wendy Rubinstein, M.D., Ph.D.
240-620-0739
rubinstw@mail.nih.gov
Wendy Rubinstein, M.D., Ph.D.
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
240-276-7332
sahasrabuddhevv@mail.nih.gov
Portrait of Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., DrPH
Goli Samimi, Ph.D., M.P.H.
240-276-6582
goli.samimi@nih.gov
Portrait of Goli Samimi, Ph.D., M.P.H.
Edward Sauter, M.D., Ph.D.
240-276-7657
edward.sauter@nih.gov
Portrait of Edward Sauter, M.D., Ph.D.

View all Staff Members

Follow us at:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

Policies

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

HHS Vulnerability Disclosure

NCI's PDQ® Evidence-based Summaries

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

General Information

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer

NIH COVID-19 Resources

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®